Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

The Platelet Response to Tissue Injury.

Eisinger F, Patzelt J, Langer HF.

Front Med (Lausanne). 2018 Nov 13;5:317. doi: 10.3389/fmed.2018.00317. eCollection 2018. Review.

2.

Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing.

Girard E, Eon-Marchais S, Olaso R, Renault AL, Damiola F, Dondon MG, Barjhoux L, Goidin D, Meyer V, Le Gal D, Beauvallet J, Mebirouk N, Lonjou C, Coignard J, Marcou M, Cavaciuti E, Baulard C, Bihoreau MT, Cohen-Haguenauer O, Leroux D, Penet C, Fert-Ferrer S, Colas C, Frebourg T, Eisinger F, Adenis C, Fajac A, Gladieff L, Tinat J, Floquet A, Chiesa J, Giraud S, Mortemousque I, Soubrier F, Audebert-Bellanger S, Limacher JM, Lasset C, Lejeune-Dumoulin S, Dreyfus H, Bignon YJ, Longy M, Pujol P, Venat-Bouvet L, Bonadona V, Berthet P, Luporsi E, Maugard CM, Noguès C, Delnatte C, Fricker JP, Gesta P, Faivre L, Lortholary A, Buecher B, Caron O, Gauthier-Villars M, Coupier I, Servant N, Boland A, Mazoyer S, Deleuze JF, Stoppa-Lyonnet D, Andrieu N, Lesueur F.

Int J Cancer. 2019 Apr 15;144(8):1962-1974. doi: 10.1002/ijc.31921. Epub 2018 Nov 13.

3.

The Mutual Relation of Platelet Activation and Innate Immunity.

Eisinger F, Langer HF.

Hamostaseologie. 2018 Nov;38(4):186-202. doi: 10.1055/s-0038-1669450. Epub 2018 Sep 25. Review.

PMID:
30253422
4.

Current and Former Smokers: Who Wants To Be Screened?

Couraud S, Greillier L, Brignoli-Guibaudet L, Lhomel C, Viguier J, Morère JF, Eisinger F, Cortot AB.

Clin Lung Cancer. 2018 Nov;19(6):493-501. doi: 10.1016/j.cllc.2018.07.001. Epub 2018 Jul 6.

PMID:
30107977
5.

Beliefs and behavior regarding e-cigarettes in a large cross-sectional survey.

Couraud S, Cortot AB, Pivot XB, Touboul C, Lhomel C, Blay JY, Eisinger F, Viguier J, Morère JF, Greillier L.

Prev Med Rep. 2018 Apr 18;10:332-336. doi: 10.1016/j.pmedr.2018.04.009. eCollection 2018 Jun.

6.

Telehealth applied to physical activity during cancer treatment: a feasibility, acceptability, and randomized pilot study.

Villaron C, Cury F, Eisinger F, Cappiello MA, Marqueste T.

Support Care Cancer. 2018 Oct;26(10):3413-3421. doi: 10.1007/s00520-018-4191-4. Epub 2018 Apr 19.

7.

Colon Cancer Screening Programs: Impact of an Organized Screening Strategy Assessed by the EDIFICE Surveys.

Viguier J, Morère JF, Brignoli-Guibaudet L, Lhomel C, Couraud S, Eisinger F.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):16. doi: 10.1007/s11912-017-0648-8.

PMID:
29508157
8.

Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.

Morère JF, Viguier J, Couraud S, Brignoli-Guibaudet L, Lhomel C, Pivot XB, Eisinger F.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):15. doi: 10.1007/s11912-017-0647-9.

PMID:
29508148
9.

Fluctuating Behavior of the French Population in Cancer Screening: 5th Edition of the EDIFICE Survey.

Viguier J, Morère JF, Pivot X, Touboul C, Lhomel C, Couraud S, de La Motte Rouge T, Eisinger F.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):14. doi: 10.1007/s11912-017-0646-x.

PMID:
29508088
10.

Perception of Lung Cancer Risk: Impact of Smoking Status and Nicotine Dependence.

Greillier L, Cortot AB, Viguier J, Brignoli-Guibaudet L, Lhomel C, Eisinger F, Morère JF, Couraud S.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):18. doi: 10.1007/s11912-017-0650-1.

PMID:
29508085
11.

Decline in Cancer Screening in Vulnerable Populations? Results of the EDIFICE Surveys.

Morère JF, Eisinger F, Touboul C, Lhomel C, Couraud S, Viguier J.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):17. doi: 10.1007/s11912-017-0649-7.

PMID:
29508084
12.

Knowledge-Based Cancer Control.

Eisinger F.

Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):19. doi: 10.1007/s11912-017-0651-0. Review. No abstract available.

PMID:
29508080
13.

GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.

Hamadou WS, Mani R, Besbes S, Bourdon V, Youssef YB, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Sobol H, Soua Z.

Ann Hematol. 2017 Oct;96(10):1635-1639. doi: 10.1007/s00277-017-3076-9. Epub 2017 Jul 27.

PMID:
28752392
14.

[Cancer screening in France: 10 years of analysis of behaviours by the EDIFICE surveys].

Eisinger F, Pivot X, Greillier L, Couraud S, Cortot AB, Touboul C, Lhomel C, Blay JY, Morère JF, Viguier J.

Bull Cancer. 2017 Mar;104(3):258-266. doi: 10.1016/j.bulcan.2016.12.002. Epub 2017 Jan 18. Review. French.

PMID:
28108012
15.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra JM, Tarpin C, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Viens P, Eisinger F, Chabannon C.

Bone Marrow Transplant. 2017 Mar;52(3):498. doi: 10.1038/bmt.2016.291. Epub 2017 Jan 16. No abstract available.

PMID:
28092355
16.

[Physical activity during cancer: Can we define participants' profiles?]

Villaron C, Marqueste T, Eisinger F, Cappiello MA, Cury F.

Bull Cancer. 2017 Mar;104(3):213-220. doi: 10.1016/j.bulcan.2016.11.020. Epub 2016 Dec 27. French.

PMID:
28034441
17.

ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.

Hamadou WS, Besbes S, Mani R, Bourdon V, Ben Youssef Y, Achour B, Regaieg H, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Sobol H, Soua Z.

Bull Cancer. 2017 Feb;104(2):123-127. doi: 10.1016/j.bulcan.2016.10.016. Epub 2016 Nov 17.

PMID:
27866680
18.

Familial hematological malignancies: new IDH2 mutation.

Hamadou WS, Bourdon V, Létard S, Brenet F, Laarif S, Besbes S, Paci A, David M, Penard-Lacronique V, Youssef YB, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Noguchi T, Khélif A, Salem CB, Dubreuil P, Sobol H, Soua Z.

Ann Hematol. 2016 Dec;95(12):1943-1947. Epub 2016 Sep 3.

PMID:
27591990
19.

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.

Gonçalves A, Bertucci F, Guille A, Garnier S, Adelaide J, Carbuccia N, Cabaud O, Finetti P, Brunelle S, Piana G, Tomassin-Piana J, Paciencia M, Lambaudie E, Popovici C, Sabatier R, Tarpin C, Provansal M, Extra JM, Eisinger F, Sobol H, Viens P, Lopez M, Ginestier C, Charafe-Jauffret E, Chaffanet M, Birnbaum D.

Oncotarget. 2016 Nov 29;7(48):79428-79441. doi: 10.18632/oncotarget.12714.

20.

Links between personality, time perspective, and intention to practice physical activity during cancer treatment: an exploratory study.

Villaron C, Marqueste T, Eisinger F, Cappiello MA, Therme P, Cury F.

Psychooncology. 2017 Apr;26(4):531-536. doi: 10.1002/pon.4194. Epub 2016 Jul 13.

PMID:
27309735
21.

Angelina and Brad effect.

Eisinger F.

Fam Cancer. 2016 Oct;15(4):541-2. doi: 10.1007/s10689-016-9908-2. No abstract available.

PMID:
27142872
22.

Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.

Hamadou WS, Bourdon V, Gaildrat P, Besbes S, Fabre A, Youssef YB, Regaieg H, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Jemni SY, Noguchi T, Khélif A, Sobol H, Soua Z.

Ann Hematol. 2016 Jun;95(7):1043-50. doi: 10.1007/s00277-016-2678-y. Epub 2016 Apr 23.

PMID:
27106701
23.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.

Boudin L, Gonçalves A, Sabatier R, Moretta J, Sfumato P, Asseeva P, Livon D, Bertucci F, Extra JM, Tarpin C, Houvenaeghel G, Lambaudie E, Tallet A, Resbeut M, Sobol H, Charafe-Jauffret E, Calmels B, Lemarie C, Boher JM, Viens P, Eisinger F, Chabannon C.

Bone Marrow Transplant. 2016 Aug;51(8):1082-6. doi: 10.1038/bmt.2016.82. Epub 2016 Apr 4. Erratum in: Bone Marrow Transplant. 2017 Mar;52(3):498.

PMID:
27042835
24.

Maintaining professional activity during breast cancer treatment.

Ganem G, Antoine EC, Touboul C, Naman H, Dohollou N, Facchini T, Coscas Y, Lortholary A, Catala S, Jacquot S, Lhomel C, Eisinger F.

Eur J Cancer Care (Engl). 2016 May;25(3):458-65. doi: 10.1111/ecc.12460. Epub 2016 Feb 18.

PMID:
26891443
25.

Ovarian cancer patients at high risk of BRCA mutation: the constitutional genetic characterization does not change prognosis.

Sabatier R, Lavit E, Moretta J, Lambaudie E, Noguchi T, Eisinger F, Cherau E, Provansal M, Livon D, Rabayrol L, Popovici C, Charaffe-Jauffret E, Sobol H, Viens P.

Fam Cancer. 2016 Oct;15(4):497-506. doi: 10.1007/s10689-016-9873-9.

PMID:
26833043
26.

GENESIS: a French national resource to study the missing heritability of breast cancer.

Sinilnikova OM, Dondon MG, Eon-Marchais S, Damiola F, Barjhoux L, Marcou M, Verny-Pierre C, Sornin V, Toulemonde L, Beauvallet J, Le Gal D, Mebirouk N, Belotti M, Caron O, Gauthier-Villars M, Coupier I, Buecher B, Lortholary A, Dugast C, Gesta P, Fricker JP, Noguès C, Faivre L, Luporsi E, Berthet P, Delnatte C, Bonadona V, Maugard CM, Pujol P, Lasset C, Longy M, Bignon YJ, Adenis C, Venat-Bouvet L, Demange L, Dreyfus H, Frenay M, Gladieff L, Mortemousque I, Audebert-Bellanger S, Soubrier F, Giraud S, Lejeune-Dumoulin S, Chevrier A, Limacher JM, Chiesa J, Fajac A, Floquet A, Eisinger F, Tinat J, Colas C, Fert-Ferrer S, Penet C, Frebourg T, Collonge-Rame MA, Barouk-Simonet E, Layet V, Leroux D, Cohen-Haguenauer O, Prieur F, Mouret-Fourme E, Cornélis F, Jonveaux P, Bera O, Cavaciuti E, Tardivon A, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, Andrieu N.

BMC Cancer. 2016 Jan 12;16:13. doi: 10.1186/s12885-015-2028-9.

27.

Travailleurs indépendants et dirigeants de très petites entreprises atteints d’un cancer : effet sur la survie entrepreneuriale.

Ha-Vinh P, Régnard P, Huiart L, Sauze L, Eisinger F.

Sante Publique. 2015 Mar-Apr;1 Suppl:145-54. French. No abstract available.

PMID:
26414268
28.

Familial hematological malignancies: ASXL1 gene investigation.

Hamadou WS, Abed RE, Besbes S, Bourdon V, Fabre A, Youssef YB, Laatiri MA, Eisinger F, Mari V, Gesta P, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Jemni SY, Noguchi T, Khélif A, Sobol H, Soua Z.

Clin Transl Oncol. 2016 Apr;18(4):385-90. doi: 10.1007/s12094-015-1379-7. Epub 2015 Aug 19.

PMID:
26286068
29.

[Self-employed and small business owners diagnosed with cancer: effect on entrepreneurial survival].

Ha-Vinh P, Régnard P, Huiart L, Sauze L, Eisinger F.

Sante Publique. 2015 Jan-Feb;27(1 Suppl):S145-54. French.

PMID:
26168628
30.

Lung cancer risks, beliefs and healthcare access among the underprivileged.

Morère JF, Viguier J, Touboul C, Pivot X, Blay JY, Coscas Y, Lhomel C, Eisinger F.

Eur J Cancer Prev. 2015 Jun;24 Suppl:S82-6. doi: 10.1097/CEJ.0000000000000143.

PMID:
26016793
31.

Social stratification, risk factor prevalence and cancer screening attendance.

Eisinger F, Viguier J, Touboul C, Coscas Y, Pivot X, Blay JY, Lhomel C, Morère JF.

Eur J Cancer Prev. 2015 Jun;24 Suppl:S77-81. doi: 10.1097/CEJ.0000000000000144.

PMID:
26016792
32.

Breast cancer screening controversy: too much or not enough?

Pivot X, Viguier J, Touboul C, Morère JF, Blay JY, Coscas Y, Lhomel C, Eisinger F.

Eur J Cancer Prev. 2015 Jun;24 Suppl:S73-6. doi: 10.1097/CEJ.0000000000000145.

PMID:
26016791
33.

Cancer screening in France: third edition of the EDIFICE survey.

Viguier J, Morère JF, Touboul C, Coscas Y, Blay JY, Lhomel C, Pivot X, Eisinger F.

Eur J Cancer Prev. 2015 Jun;24 Suppl:S68-72. doi: 10.1097/CEJ.0000000000000146.

PMID:
26016790
34.

Cancer screening: continuing instability.

Eisinger F.

Eur J Cancer Prev. 2015 Jun;24 Suppl:S65-7. doi: 10.1097/CEJ.0000000000000147. No abstract available.

PMID:
26016789
35.

Prostate cancer screening: contrasting trends.

Eisinger F, Morère JF, Touboul C, Pivot X, Coscas Y, Blay JY, Lhomel C, Viguier J.

Cancer Causes Control. 2015 Jun;26(6):949-52. doi: 10.1007/s10552-015-0573-9. Epub 2015 Mar 31.

PMID:
25822574
36.

Melanoma risk-takers: fathers and sons.

Eisinger F, Morère JF, Pivot X, Grange F, Lhomel C, Mortier L, Robert C, Saiag P, Sassolas B, Viguier J.

J Eur Acad Dermatol Venereol. 2015 Feb;29 Suppl 2:35-8. doi: 10.1111/jdv.12901.

PMID:
25639932
37.

Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers.

Lecarpentier J, Noguès C, Mouret-Fourme E, Buecher B, Gauthier-Villars M, Stoppa-Lyonnet D, Bonadona V, Fricker JP, Berthet P, Caron O, Coupier I, Pujol P, Faivre L, Gesta P, Eisinger F, Mari V, Gladieff L, Lortholary A, Luporsi E, Leroux D, Venat-Bouvet L, Maugard CM, Colas C, Tinat J, Lasset C, Andrieu N; GENEPSO.

Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):698-707. doi: 10.1158/1055-9965.EPI-14-0884. Epub 2015 Jan 22.

38.

Cigarette smoking in women after BRCA1/2 genetic test disclosure: a 5-year follow-up study of the GENEPSO PS cohort.

Julian-Reynier C, Resseguier N, Bouhnik AD, Eisinger F, Lasset C, Fourme E, Noguès C.

Genet Med. 2015 Feb;17(2):117-24. doi: 10.1038/gim.2014.82. Epub 2014 Jul 10.

PMID:
25010056
39.

[Exposure to animals and non-Hodgkin lymphomas: pilot analysis about 261 cases].

Jeanne A, Aras M, Eisinger F, Bellagamba G, Garciaz S, Lehucher-Michel MP, Bouabdallah R.

Bull Cancer. 2014 Mar;101(3):236-42. doi: 10.1684/bdc.2014.1902. French.

PMID:
24691187
40.

[Personalized medicine and breast cancer: anticipatory medicine, prognostic evaluation and therapeutic targeting].

Gonçalves A, Moretta J, Eisinger F, Bertucci F.

Bull Cancer. 2013 Dec;100(12):1295-310. doi: 10.1684/bdc.2013.1856. Review. French.

PMID:
24225763
41.

[Pharmaco and diet based prostate cancer prevention].

Eisinger F, Cancel-Tassin G, Azzouzi AR, Gravis G, Rossi D, Cussenot O.

Bull Cancer. 2013 May;100(5):497-507. doi: 10.1684/bdc.2013.1739. Review. French.

PMID:
23694994
42.

Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.

Hassanein M, Huiart L, Bourdon V, Rabayrol L, Geneix J, Nogues C, Peyrat JP, Gesta P, Meynard P, Dreyfus H, Petrot D, Lidereau R, Noguchi T, Eisinger F, Extra JM, Viens P, Jacquemier J, Sobol H.

Pathobiology. 2013;80(5):219-27. doi: 10.1159/000339432. Epub 2013 Apr 23.

43.

Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012.

Rahner N, Steinke V, Schlegelberger B, Eisinger F, Hutter P, Olschwang S.

Eur J Hum Genet. 2013 Jan;21(1). doi: 10.1038/ejhg.2012.164. Epub 2012 Aug 15. No abstract available.

44.

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Lecarpentier J, Noguès C, Mouret-Fourme E, Gauthier-Villars M, Lasset C, Fricker JP, Caron O, Stoppa-Lyonnet D, Berthet P, Faivre L, Bonadona V, Buecher B, Coupier I, Gladieff L, Gesta P, Eisinger F, Frénay M, Luporsi E, Lortholary A, Colas C, Dugast C, Longy M, Pujol P, Tinat J; GENEPSO, Lidereau R, Andrieu N.

Breast Cancer Res. 2012 Jul 3;14(4):R99. doi: 10.1186/bcr3218.

45.

Use of daptomycin for the treatment of methicillin-resistant coagulase-negative staphylococcal ventriculitis.

Erritouni M, Ktaich N, Rahal JJ, Figueroa D, Nieto J, Urban C, Mariano N, Eisinger F, Abayev J, Nicolau D, Rubin D, Raifu M, Segal-Maurer S.

Case Rep Med. 2012;2012:593578. doi: 10.1155/2012/593578. Epub 2012 May 9.

46.

Spontaneous disclosure of BRCA1/2 genetic test results to employers: a French prospective study.

Eisinger F, Fabre R, Lasset C, Stoppa-Lyonnet D, Julian-Reynier C, Nogues C.

Eur J Hum Genet. 2012 Sep;20(9):981-3. doi: 10.1038/ejhg.2012.37. Epub 2012 Feb 29.

47.

[Systemic learning planification for medical students during oncology clinical rotation].

Gonçalves A, Viens P, Gilabert M, Turrini O, Lambaudie E, Prebet T, Farnault B, Eisinger F, Gorincour G, Bertucci F.

Bull Cancer. 2011 Dec;98(12):1489-508. doi: 10.1684/bdc.2011.1504. French.

48.

Increasing coverage rates for mammographic screening in France in older women--16 years of follow-up.

Eisinger F, Beck F, Viguier J, Blay JY, Coscas Y, Roussel C, Morère JF, Pivot X.

Breast J. 2011 Nov-Dec;17(6):686-8. doi: 10.1111/j.1524-4741.2011.01169.x. No abstract available.

PMID:
22050283
49.

Molecular study of the perforin gene in familial hematological malignancies.

El Abed R, Bourdon V, Voskoboinik I, Omri H, Youssef YB, Laatiri MA, Huiart L, Eisinger F, Rabayrol L, Frenay M, Gesta P, Demange L, Dreyfus H, Bonadona V, Dugast C, Zattara H, Faivre L, Zaier M, Jemni SY, Noguchi T, Sobol H, Soua Z.

Hered Cancer Clin Pract. 2011 Sep 21;9(1):9. doi: 10.1186/1897-4287-9-9.

50.

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.

Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL; Ontario Cancer Genetics Network, Thomassen M, Gerdes AM, Caligo MA, Friedman E, Laitman Y, Kaufman B, Paluch SS, Borg Å, Karlsson P, Askmalm MS, Bustinza GB; SWE-BRCA Collaborators, Nathanson KL, Domchek SM, Rebbeck TR, Benítez J, Hamann U, Rookus MA, van den Ouweland AM, Ausems MG, Aalfs CM, van Asperen CJ, Devilee P, Gille HJ; HEBON; EMBRACE, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Paterson J, Eason J, Godwin AK, Remon MA, Moncoutier V, Gauthier-Villars M, Lasset C, Giraud S, Hardouin A, Berthet P, Sobol H, Eisinger F, Bressac de Paillerets B, Caron O, Delnatte C; GEMO Study Collaborators, Goldgar D, Miron A, Ozcelik H, Buys S, Southey MC, Terry MB; Breast Cancer Family Registry, Singer CF, Dressler AC, Tea MK, Hansen TV, Johannsson O, Piedmonte M, Rodriguez GC, Basil JB, Blank S, Toland AE, Montagna M, Isaacs C, Blanco I, Gayther SA, Moysich KB, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Sutter C, Gadzicki D, Fiebig B, Caldes T, Laframboise R, Nevanlinna H, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Ding YC, Couch FJ, Wang X, Peterlongo P, Manoukian S, Bernard L, Radice P, Easton DF, Chenevix-Trench G, Antoniou AC, Stoppa-Lyonnet D, Mazoyer S, Sinilnikova OM; Consortium of Investigators of Modifiers of BRCA1/2.

Hum Mol Genet. 2011 Dec 1;20(23):4732-47. doi: 10.1093/hmg/ddr388. Epub 2011 Sep 2.

Supplemental Content

Loading ...
Support Center